https://www.hcplive.com/view/weight-loss-program-cuts-vascular-events-67-after-minor-stroke-tia2026-10-28T21:00:03.862Z2026-10-28T21:00:03.862Z https://www.hcplive.com/view/abcs-in-dermatology-topical-pde4-inhibition-in-atopic-dermatitis2026-10-28T21:00:00Z2026-10-28T21:00:00Z https://www.hcplive.com/view/the-medical-sisterhood-how-approach-burnout-boundaries-authenticity-in-medicine2026-10-28T18:00:41.436Z2026-10-28T18:00:41.436Z https://www.hcplive.com/view/new-international-igg4-rd-guidelines-and-the-road-ahead2026-10-28T16:15:24.575Z2026-10-28T16:15:24.575Z https://www.hcplive.com/view/malignancy-risk-in-igg4-rd-interpreting-conflicting-evidence2026-10-28T16:15:23.156Z2026-10-28T16:15:23.156Z https://www.hcplive.com/view/defining-treatment-success-switching-therapy-and-managing-igg4-rd-complications2026-10-28T16:15:21.595Z2026-10-28T16:15:21.595Z https://www.hcplive.com/view/long-term-monitoring-in-igg4-rd-imaging-serology-and-visit-frequency2026-10-28T16:15:19.920Z2026-10-28T16:15:19.920Z https://www.hcplive.com/view/emerging-igg4-rd-therapies-cellular-oral-and-pathway-targeted-approaches2026-10-28T16:15:18.242Z2026-10-28T16:15:18.242Z https://www.hcplive.com/view/positioning-b-cell-depletion-and-b-cell-inhibition-in-igg4-rd-care2026-10-28T16:15:16.797Z2026-10-28T16:15:16.797Z https://www.hcplive.com/view/b-cell-inhibition-in-igg4-rd-phase-3-trial-design-and-outcomes2026-10-28T16:15:14.964Z2026-10-28T16:15:14.964Z https://www.hcplive.com/view/anti-cd19-b-cell-depletion-in-igg4-rd-phase-3-data-and-practice2026-10-28T16:15:13.500Z2026-10-28T16:15:13.500Z https://www.hcplive.com/view/monitoring-and-safety-considerations-with-anti-cd20-therapy-in-igg4-rd2026-10-28T16:15:11.958Z2026-10-28T16:15:11.958Z https://www.hcplive.com/view/anti-cd20-b-cell-depletion-for-inducing-remission-in-igg4-rd2026-10-28T16:15:10.389Z2026-10-28T16:15:10.389Z https://www.hcplive.com/view/predicting-relapse-in-igg4-rd-risk-factors-and-ongoing-surveillance2026-10-28T16:15:08.873Z2026-10-28T16:15:08.873Z https://www.hcplive.com/view/glucocorticoid-toxicity-in-igg4-rd-why-shorter-steroid-courses-matter2026-10-28T16:15:07.563Z2026-10-28T16:15:07.563Z https://www.hcplive.com/view/rethinking-glucocorticoids-as-first-line-therapy-in-igg4-rd2026-10-28T16:15:06.046Z2026-10-28T16:15:06.046Z https://www.hcplive.com/view/individualizing-igg4-rd-treatment-around-comorbidities-and-limited-options2026-10-28T16:15:04.551Z2026-10-28T16:15:04.551Z https://www.hcplive.com/view/b-cells-in-igg4-rd-pathogenesis-and-setting-treatment-goals2026-10-28T16:15:03.093Z2026-10-28T16:15:03.093Z https://www.hcplive.com/view/the-cost-of-delayed-igg4-rd-diagnosis-organ-damage-and-relapse2026-10-28T16:15:00.897Z2026-10-28T16:15:00.897Z https://www.hcplive.com/view/pah-practice-pearls-risk-assessment-right-heart-focus-and-optimism2026-10-28T16:12:07.038Z2026-10-28T16:12:07.038Z https://www.hcplive.com/view/pah-vs-left-heart-ph-echo-clues-and-overlapping-physiology2026-10-28T16:12:05.357Z2026-10-28T16:12:05.357Z https://www.hcplive.com/view/pah-s-evolving-landscape-pipeline-therapies-diagnostic-gaps-and-older-patients2026-10-28T16:12:03.582Z2026-10-28T16:12:03.582Z https://www.hcplive.com/view/pah-treatment-adherence-and-quality-of-life-reducing-pill-burden2026-10-28T16:12:02.123Z2026-10-28T16:12:02.123Z https://www.hcplive.com/view/pah-medication-side-effects-tolerability-titration-and-shared-decision-making2026-10-28T16:12:00.449Z2026-10-28T16:12:00.449Z https://www.hcplive.com/view/stepping-down-from-parenteral-therapy-in-pah-oral-prostacyclin-pathway-options2026-10-28T16:11:58.887Z2026-10-28T16:11:58.887Z https://www.hcplive.com/view/the-fourth-pah-pathway-activin-signaling-inhibitors-and-parenteral-therapy2026-10-28T16:11:57.537Z2026-10-28T16:11:57.537Z https://www.hcplive.com/view/escalating-pah-therapy-setting-expectations-and-choosing-the-next-step2026-10-28T16:11:56.038Z2026-10-28T16:11:56.038Z https://www.hcplive.com/view/pah-risk-scores-vs-right-heart-function-interpreting-echo-beyond-pressure2026-10-28T16:11:54.528Z2026-10-28T16:11:54.528Z https://www.hcplive.com/view/assessing-treatment-response-in-pah-longitudinal-follow-up-and-the-right-ventricle2026-10-28T16:11:52.999Z2026-10-28T16:11:52.999Z https://www.hcplive.com/view/treating-established-vs-newly-diagnosed-pah-confirming-the-diagnosis-first2026-10-28T16:11:51.291Z2026-10-28T16:11:51.291Z https://www.hcplive.com/view/fixed-dose-combination-therapy-in-pah-simplifying-upfront-treatment2026-10-28T16:11:49.611Z2026-10-28T16:11:49.611Z https://www.hcplive.com/view/initial-pah-therapy-upfront-dual-oral-combination-and-guideline-risk-stratification2026-10-28T16:11:47.710Z2026-10-28T16:11:47.710Z https://www.hcplive.com/view/treating-depression-in-ckd-after-concord-with-susan-hedayati-md-mhsc2026-10-28T14:25:21.098Z2026-10-28T14:25:21.098Z https://www.hcplive.com/view/concord-trial-results-in-ckd-depression-with-susan-hedayati-md-mhsc2026-10-28T14:09:08.529Z2026-10-28T14:09:08.529Z https://www.hcplive.com/view/the-evolving-standard-of-care-of-classic-congenital-adrenal-hyperplasia2026-10-28T14:00:00Z2026-10-28T14:00:00Z https://www.hcplive.com/view/transcend-t2d-2-retatrutide-beats-semaglutide-2-mg-on-a1c-weight-loss2026-10-28T13:47:13.698Z2026-10-28T13:47:13.698Z https://www.hcplive.com/view/robotic-bronchoscopy-shows-87-malignancy-sensitivity-pritchett2026-10-27T20:54:10.904Z2026-10-27T20:54:10.904Z https://www.hcplive.com/view/orka-001-clears-skin-in-61-high-dose-psoriasis-patients-week-162026-10-27T20:20:42.156Z2026-10-27T20:20:42.156Z https://www.hcplive.com/view/respiratory-monitoring-spinal-muscular-atrophy-gene-therapy2026-10-27T18:38:00Z2026-10-27T18:38:00Z https://www.hcplive.com/view/closing-the-care-gap-for-antihistamine-refractory-cindu2026-10-27T18:13:59.755Z2026-10-27T18:13:59.755Z https://www.hcplive.com/view/biomarkers-and-early-intervention-can-treatment-timing-change-cindu-s-course2026-10-27T18:13:57.943Z2026-10-27T18:13:57.943Z https://www.hcplive.com/view/personalizing-advanced-therapy-selection-for-cindu-subtypes2026-10-27T18:13:56.081Z2026-10-27T18:13:56.081Z https://www.hcplive.com/view/monitoring-advanced-therapies-for-cindu-in-clinical-practice2026-10-27T18:13:54.671Z2026-10-27T18:13:54.671Z https://www.hcplive.com/view/updated-urticaria-guidelines-and-emerging-mechanisms-in-cindu2026-10-27T18:13:52.831Z2026-10-27T18:13:52.831Z https://www.hcplive.com/view/defining-treatment-success-and-switching-treatment-in-cindu2026-10-27T18:13:51.135Z2026-10-27T18:13:51.135Z https://www.hcplive.com/view/remibrutinib-safety-in-cindu-bleeding-surgery-and-immunoglobulins2026-10-27T18:13:49.409Z2026-10-27T18:13:49.409Z https://www.hcplive.com/view/remind-trial-results-btk-inhibition-across-three-cindu-subtypes2026-10-27T18:13:48.017Z2026-10-27T18:13:48.017Z https://www.hcplive.com/view/off-label-biologics-in-cindu-real-world-lessons-and-mixed-evidence2026-10-27T18:13:46.567Z2026-10-27T18:13:46.567Z https://www.hcplive.com/view/beyond-antihistamines-mapping-cindu-therapies-to-the-mast-cell2026-10-27T18:13:44.345Z2026-10-27T18:13:44.345Z https://www.hcplive.com/view/bioengineered-vessel-adds-91-catheter-free-days-for-women-on-dialysis2026-10-27T18:04:44.136Z2026-10-27T18:04:44.136Z https://www.hcplive.com/view/bioengineered-vessel-for-dialysis-access-integrates-with-patient-cells2026-10-27T18:04:44.136Z2026-10-27T18:04:44.136Z https://www.hcplive.com/view/phinder-pvd-b65-ph-ild-screening-parth-rali2026-10-27T17:03:00Z2026-10-27T17:03:00Z https://www.hcplive.com/view/new-aha-acc-acute-pulmonary-embolism-categories2026-10-27T16:25:00Z2026-10-27T16:25:00Z https://www.hcplive.com/view/tpip-efficacy-holds-palm-ild-advances-church2026-10-27T16:19:01.529Z2026-10-27T16:19:01.529Z https://www.hcplive.com/view/tpip-tolerable-over-2-years-ph-ild-church2026-10-27T16:07:07.362Z2026-10-27T16:07:07.362Z https://www.hcplive.com/view/ai-copd-prognosis-bourbeau2026-10-27T15:07:00Z2026-10-27T15:07:00Z https://www.hcplive.com/view/breath-hold-does-not-improve-robotic-bronchoscopy-yield-stable-trial2026-10-27T14:24:00Z2026-10-27T14:24:00Z https://www.hcplive.com/view/tradipitant-cuts-semaglutide-induced-vomiting-in-phase-3-trial2026-10-27T13:00:00Z2026-10-27T13:00:00Z https://www.hcplive.com/view/pah-care-teams-unmet-needs-and-the-four-treatment-pathways2026-10-27T12:05:00Z2026-10-27T12:05:00Z https://www.hcplive.com/view/individualizing-initial-treatment-selection-in-eoe2026-10-27T12:05:00Z2026-10-27T12:05:00Z https://www.hcplive.com/view/recognizing-progression-and-fibrostenotic-disease-in-eoe2026-10-27T12:00:00Z2026-10-27T12:00:00Z https://www.hcplive.com/view/q-a-early-career-dermatology-pearls-defensive-patients-hs-coding2026-10-27T12:00:00Z2026-10-27T12:00:00Z https://www.hcplive.com/view/pah-risk-assessment-why-reaching-low-risk-matters-for-patients2026-10-27T12:00:00Z2026-10-27T12:00:00Z https://www.hcplive.com/view/diabetes-dialogue-a-consensus-definition-for-fully-closed-loop-systems2026-10-27T11:00:00Z2026-10-27T11:00:00Z https://www.hcplive.com/view/trigger-avoidance-and-antihistamine-up-dosing-in-cindu2026-10-27T06:13:00Z2026-10-27T06:13:00Z https://www.hcplive.com/view/the-hidden-quality-of-life-and-mental-health-burden-of-cindu2026-10-27T06:13:00Z2026-10-27T06:13:00Z https://www.hcplive.com/view/va-dialysis-tied-to-lower-mortality-with-virginia-wang-phd-msph2026-10-26T21:00:38.417Z2026-10-26T21:00:38.417Z https://www.hcplive.com/view/ad109-cuts-ahi-postmenopausal-women-osa2026-10-26T20:40:00Z2026-10-26T20:40:00Z https://www.hcplive.com/view/which-lvo-stroke-patients-benefit-edaravone-dexborneol-before-evt-2026-10-26T20:00:00Z2026-10-26T20:00:00Z https://www.hcplive.com/view/inhaled-treprostinil-reduces-recurrent-ipf-events2026-10-26T18:51:00Z2026-10-26T18:51:00Z https://www.hcplive.com/view/skin-color-savvy-recalibrating-clinical-lens-skin-color-dermatology2026-10-26T18:00:26.570Z2026-10-26T18:00:26.570Z https://www.hcplive.com/view/what-drives-balcinrenone-s-bp-effect-with-adriana-marton-md2026-10-26T16:00:51.151Z2026-10-26T16:00:51.151Z https://www.hcplive.com/view/balcinrenone-plus-dapagliflozin-lowers-bp-with-adriana-marton-md2026-10-26T15:25:09.184Z2026-10-26T15:25:09.184Z https://www.hcplive.com/view/q-a-looking-beyond-body-surface-area-atopic-dermatitis-treatment-selection2026-10-26T15:06:54.910Z2026-10-26T15:12:34.640Z https://www.hcplive.com/view/quality-of-life-in-igg4-rd-disease-damage-and-fear-of-relapse2026-10-26T12:05:00Z2026-10-26T12:05:00Z https://www.hcplive.com/view/redefining-treatment-goals-and-patient-expectations-in-pso2026-10-26T12:05:00Z2026-10-26T12:05:00Z https://www.hcplive.com/view/diagnosing-igg4-rd-why-classification-criteria-are-not-diagnostic-criteria2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.hcplive.com/view/evolving-treatment-options-in-pso2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.hcplive.com/view/hcpfive-top-news-healthcare-providers-week-of-10-182026-10-26T01:00:14.612Z2026-10-26T01:00:14.612Z https://www.hcplive.com/view/42-on-povetacicept-reach-kdigo-aligned-upcr-target-in-rainier2026-10-25T18:06:23.169Z2026-10-25T18:06:23.169Z https://www.hcplive.com/view/egfr-underestimates-ckd-in-patients-with-cancer-study-finds2026-10-25T18:00:00Z2026-10-25T18:00:00Z https://www.hcplive.com/view/tegoprubart-improves-quality-of-life-vs-tacrolimus-after-kidney-transplant2026-10-25T16:00:00Z2026-10-25T16:00:00Z https://www.hcplive.com/view/kidney-compass-new-find-ckd-finerenone-data-from-asn-kidney-week-20262026-10-24T23:00:00Z2026-10-24T23:00:00Z https://www.hcplive.com/view/glp-1s-tied-to-weight-loss-in-peritoneal-dialysis-with-steven-brunelli-md2026-10-24T21:52:59.134Z2026-10-24T21:52:59.134Z https://www.hcplive.com/view/why-patients-miss-dialysis-treatments-with-steven-brunelli-md2026-10-24T21:52:59.134Z2026-10-24T21:52:59.134Z https://www.hcplive.com/view/upacicalcet-lowers-pth-in-secondary-hyperparathyroidism-on-hemodialysis2026-10-24T21:00:00Z2026-10-24T21:00:00Z https://www.hcplive.com/view/matching-ckd-education-to-patient-readiness-for-home-dialysis-with-christopher-chan-md2026-10-24T18:00:00Z2026-10-24T18:00:00Z https://www.hcplive.com/view/renew-hd-portable-hemodialysis-data-with-karin-gerritsen-md-phd2026-10-24T16:27:29.694Z2026-10-24T16:27:29.694Z https://www.hcplive.com/view/kidney-compass-final-2-year-teligan-data-for-telitacicept-in-iga-nephropathy2026-10-24T16:00:00Z2026-10-24T16:00:00Z https://www.hcplive.com/view/sparsentan-lowers-inflammatory-complement-biomarkers-in-igan2026-10-24T15:00:00Z2026-10-24T15:00:00Z https://www.hcplive.com/view/diabetes-dialogue-minimed-vivera-data-and-twiist-type-2-clearance2026-10-23T21:00:26.592Z2026-10-23T21:00:26.592Z https://www.hcplive.com/view/ai-find-undiagnosed-copd-lung-cancer-screening-ct2026-10-23T20:44:29.249Z2026-10-23T20:44:29.249Z https://www.hcplive.com/view/attack-should-patients-with-ckd-start-aspirin-for-primary-prevention-2026-10-23T20:30:00Z2026-10-23T20:30:00Z https://www.hcplive.com/view/tenapanor-lowers-serum-phosphate-regardless-of-binder-use-in-dialysis2026-10-23T20:30:00Z2026-10-23T20:30:00Z https://www.hcplive.com/view/fda-approves-subcutaneous-risankizumab-crohns-disease2026-10-23T20:18:44.321Z2026-10-23T20:18:44.321Z https://www.hcplive.com/view/3-year-nemolizumab-data-atopic-dermatitis-sarina-elmariah-md-phd2026-10-23T20:00:00Z2026-10-23T20:00:00Z https://www.hcplive.com/view/ralinepag-benefit-spans-broad-pah-population-elwing2026-10-23T19:51:31.857Z2026-10-23T19:51:31.857Z https://www.hcplive.com/view/ralinepag-cuts-pah-worsening-low-risk-patients-elwing2026-10-23T19:13:25.540Z2026-10-23T19:13:25.540Z https://www.hcplive.com/view/can-delivering-fruits-and-vegetables-address-ckd-acidosis-with-navdeep-tangri-md2026-10-23T19:00:00Z2026-10-23T19:00:00Z https://www.hcplive.com/view/does-ckd-require-restricting-potassium-rich-foods-with-navdeep-tangri-md2026-10-23T18:30:31.576Z2026-10-23T18:30:31.576Z